Chiang Anne C
From the Yale University School of Medicine, New Haven, CT.
Am Soc Clin Oncol Educ Book. 2016;35:e102-7. doi: 10.1200/EDBK_160113.
The nature and cost of cancer care is evolving, affecting more patients and often involving expensive treatment options. The upward cost trends also coincide with a national landscape of increasing regulatory mandates that may demand improved outcomes and value, but that often require significant up-front investment in infrastructure to achieve safety and quality. Oncology practices participating in the American Society of Clinical Oncology (ASCO) Institute for Quality's Quality Oncology Practice Initiative (QOPI) and the QOPI Certification Program (QCP) continue to grow in number and reflect changing demographics of the provision of cancer care. QOPI and QCP benchmarking can be used to achieve quality improvement and to build collaborative quality communities. These programs may be useful tools for oncology practices to comply with new legislation such as the Medicare Access and CHIP Reauthorization Act (MACRA).
癌症护理的性质和成本正在不断演变,影响着越来越多的患者,并且常常涉及昂贵的治疗选择。成本上升趋势也与国家层面日益增加的监管要求相契合,这些要求可能需要改善治疗效果和价值,但往往需要在基础设施方面进行大量前期投资以实现安全性和质量。参与美国临床肿瘤学会(ASCO)质量研究所的肿瘤学质量实践倡议(QOPI)和QOPI认证计划(QCP)的肿瘤学实践数量持续增长,反映了癌症护理服务不断变化的人口统计学特征。QOPI和QCP基准可用于实现质量改进和建立协作性质量社区。这些计划可能是肿瘤学实践遵守诸如《医疗保险准入和儿童健康保险计划再授权法案》(MACRA)等新立法的有用工具。